Order Article Reprints

Choueiry F, Singh S, Sircar A, Laliotis G, Sun X, Chavdoula E, Zhang S, Helmig-Mason J, Hart A, Epperla N, et al. Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma. Cancers. 2021; 13(9):2146. https://doi.org/10.3390/cancers13092146

Choueiry, Fouad, Satishkumar Singh, Anuvrat Sircar, Georgios Laliotis, Xiaowei Sun, Evangelia Chavdoula, Shiqi Zhang, JoBeth Helmig-Mason, Amber Hart, Narendranath Epperla, and et al. 2021. "Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma" Cancers 13, no. 9: 2146. https://doi.org/10.3390/cancers13092146

Choueiry, F., Singh, S., Sircar, A., Laliotis, G., Sun, X., Chavdoula, E., Zhang, S., Helmig-Mason, J., Hart, A., Epperla, N., Tsichlis, P., Baiocchi, R., Alinari, L., Zhu, J., & Sehgal, L. (2021). Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma. Cancers, 13(9), 2146. https://doi.org/10.3390/cancers13092146